HDFC Securities
Revenue decreased by 4.98% to Rs. 876.29 Cr in Q3FY17 when compared to the previous quarter. On the other hand, it grew by 5.11% when compared with Q3FY16.
Strides Pharma Science Ltd. is trading above its 200 day SMA of 975.4
More from Strides Pharma Science Ltd.
Recommended